Significance of Prion and Prion-Like Proteins in Cancer Development, Progression and Multi-Drug Resistance

E-ISSN： 1873-5576|13|8|895-904

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.13, Iss.8, 2013-10, pp. : 895-904

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Multi-drug resistance and cancer

By Atalay Can

Expert Opinion on Therapeutic Patents, Vol. 17, Iss. 5, 2007-05 ,pp. : 511-520

Informa Healthcare

Access to resources Recommend Favorite

Strain Specificity and Drug Resistance in Anti-Prion Therapy

Current Topics in Medicinal Chemistry, Vol. 13, Iss. 19, 2013-10 ,pp. : 2397-2406

Bentham Science Publishers

Access to resources Recommend Favorite

Modelling neurodegeneration in prion disease – applications for drug development

By Uppington Kay M Brown David R

Expert Opinion on Drug Discovery, Vol. 2, Iss. 6, 2007-06 ,pp. : 777-788

Informa Healthcare

Access to resources Recommend Favorite

Substrates and Inhibitors of Human Multidrug Resistance Associated Proteins and the Implications in Drug Development

Current Medicinal Chemistry, Vol. 15, Iss. 20, 2008-08 ,pp. : 1981-2039

Bentham Science Publishers

Access to resources Recommend Favorite

Recent strategies for the treatment of multi-drug resistance in cancer cells

By Ojima I. Bounaud P-Y. Oderda C.F.

Expert Opinion on Therapeutic Patents, Vol. 8, Iss. 12, 1998-12 ,pp. : 1587-1598

Informa Healthcare

Access to resources Recommend Favorite